scholarly article | Q13442814 |
P50 | author | Melanie K B Wills | Q84964706 |
P2093 | author name string | Iain L Mainprize | |
Jonathan F Lovell | |||
Yi-Pin Lin | |||
Wei-Chiao Huang | |||
Jasmin Federizon | |||
Xuedan He | |||
Thomas M Hart | |||
Christopher Beltran | |||
Amber Frye | |||
Ashley L Marcinkiewicz | |||
P2860 | cites work | The Lyme vaccine: a cautionary tale | Q22251377 |
Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide | Q24630127 | ||
Vaccine Adjuvants: from 1920 to 2015 and Beyond | Q26783879 | ||
Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA | Q27629686 | ||
TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi | Q28292578 | ||
Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice | Q33584120 | ||
Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background | Q34120882 | ||
Enhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP. | Q34183802 | ||
Mechanism of action of cytochalasin B on actin | Q34272923 | ||
Design and development of a novel vaccine for protection against Lyme borreliosis | Q34542417 | ||
Functionalization of cobalt porphyrin-phospholipid bilayers with his-tagged ligands and antigens. | Q35535265 | ||
The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice | Q35915376 | ||
An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope | Q36017879 | ||
Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine | Q36366055 | ||
Liposomes as carriers of antigens and adjuvants | Q36660595 | ||
Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice | Q37058962 | ||
Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease | Q37099227 | ||
Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens | Q37191759 | ||
The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes | Q38597818 | ||
SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure | Q39118758 | ||
Infection Rate by Trypanosoma cruzi and Biased Vertebrate Host Selection in the Triatoma dimidiata (Hemiptera: Reduvidae) Species Complex | Q39381514 | ||
Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development | Q40223320 | ||
Characterization and optimization of a novel vaccine for protection against Lyme borreliosis | Q40305701 | ||
NMR identification of epitopes of Lyme disease antigen OspA to monoclonal antibodies. | Q47781258 | ||
Identification of Lyme borreliae proteins promoting vertebrate host blood-specific spirochete survival in Ixodes scapularis nymphs using artificial feeding chambers. | Q52322007 | ||
An in vitro feeding assay to test acaricides for control of hard ticks. | Q52673982 | ||
A silicone membrane for in vitro feeding of Ixodes scapularis (Ixodida: Ixodidae). | Q53763278 | ||
Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. | Q54312791 | ||
Lyme borreliosis | Q56764150 | ||
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines | Q57094639 | ||
Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA | Q57266635 | ||
A malaria vaccine adjuvant based on recombinant antigen binding to liposomes | Q57295566 | ||
The Spirochetal Etiology of Lyme Disease | Q58402764 | ||
Structural analysis of an outer surface protein from the Lyme disease spirochete, Borrelia burgdorferi, using circular dichroism and fluorescence spectroscopy | Q68083619 | ||
Lipoproteins from Borrelia burgdorferi applied in liposomes and presented by dendritic cells induce CD8(+) T-lymphocytes in vitro | Q73834081 | ||
Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts | Q90670739 | ||
Antigen Engineering Approaches for Lyme Disease Vaccines | Q93105912 | ||
"Ticking Bomb": The Impact of Climate Change on the Incidence of Lyme Disease | Q93354155 | ||
P433 | issue | 4 | |
P921 | main subject | Lyme disease | Q201989 |
P304 | page(s) | 942-950 | |
P577 | publication date | 2019-11-11 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes | |
P478 | volume | 38 |
Q90699157 | Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment | cites work | P2860 |
Search more.